CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Apr 15, 2013 · 10-Q · 46 days after period end · 0001303681-13-000024
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Net Income | -$4.64K | -$1.85K | $2.98K |
| EPS Diluted | -$0.01 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended Feb 28, 2013 · filed Apr 15, 2013 · 46 d after period end
